Chapter 1. INTRAVENOUS THERAPY MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. INTRAVENOUS THERAPY MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. INTRAVENOUS THERAPY MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. INTRAVENOUS THERAPY MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. INTRAVENOUS THERAPY MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. INTRAVENOUS THERAPY MARKET – by Type

6.1. Hypodermic Needles

6.2. Implantable Ports

6.3. Infusion Pumps

6.4.Intravenous Catheters

6.5. Other

Chapter 7. INTRAVENOUS THERAPY MARKET – By Medical Application

7.1. Medication Administration

7.2. Nutrition And Buffer Solution

7.3. Volume Expander

7.4. Blood Based Products

Chapter 8. INTRAVENOUS THERAPY MARKET – By End User

8.1.  Ambulatory Surgical Center

8.2. Clinics

8.3. Hospitals

Chapter 9. INTRAVENOUS THERAPY MARKET – By Region

9.1. North America

9.2. Europe

9.3.The Asia Pacific

9.4.Latin America

9.5. Middle-East and Africa

Chapter 10. INTRAVENOUS THERAPY MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10